Filing Details
- Accession Number:
- 0001209191-23-027770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-05 17:03:01
- Reporting Period:
- 2023-05-03
- Accepted Time:
- 2023-05-05 17:03:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645569 | Dice Therapeutics Inc. | DICE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1638944 | Kevin Judice | C/O Dice Therapeutics, Inc. 400 East Jamie Court, Suite 300 South San Francisco CA 94080 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-03 | 13,698 | $36.50 | 799,685 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 28, 2022.